A09855 Summary:
BILL NO | A09855A |
  | |
SAME AS | No same as |
  | |
SPONSOR | Zebrowski (MS) |
  | |
COSPNSR | Cusick, Ortiz, Maisel, Sweeney, Galef, Colton, Rivera P, Russell, Brindisi, Jaffee, Castro, Titus, Robinson, Gabryszak, Scarborough, Gunther, Reilly, Cook, Titone, Magnarelli, Barrett, Boyland |
  | |
MLTSPNSR | Barclay, Barron, Burling, Calhoun, Castelli, Ceretto, Crouch, Dinowitz, Duprey, Finch, Hawley, Jordan, Lopez P, Losquadro, Magee, McKevitt, Montesano, Murray, Nolan, Palmesano, Peoples-Stokes, Perry, Tobacco |
  | |
Amd S3306, Pub Health L | |
  | |
Adds synthetic cannabinoids to the schedule of controlled substances. |
A09855 Actions:
BILL NO | A09855A | |||||||||||||||||||||||||||||||||||||||||||||||||
  | ||||||||||||||||||||||||||||||||||||||||||||||||||
04/18/2012 | referred to health | |||||||||||||||||||||||||||||||||||||||||||||||||
05/03/2012 | amend (t) and recommit to health | |||||||||||||||||||||||||||||||||||||||||||||||||
05/03/2012 | print number 9855a | |||||||||||||||||||||||||||||||||||||||||||||||||
05/22/2012 | reported referred to codes | |||||||||||||||||||||||||||||||||||||||||||||||||
05/22/2012 | reported referred to rules | |||||||||||||||||||||||||||||||||||||||||||||||||
05/22/2012 | reported | |||||||||||||||||||||||||||||||||||||||||||||||||
05/22/2012 | rules report cal.35 | |||||||||||||||||||||||||||||||||||||||||||||||||
05/22/2012 | ordered to third reading rules cal.35 | |||||||||||||||||||||||||||||||||||||||||||||||||
05/23/2012 | passed assembly | |||||||||||||||||||||||||||||||||||||||||||||||||
05/23/2012 | delivered to senate | |||||||||||||||||||||||||||||||||||||||||||||||||
05/23/2012 | REFERRED TO HEALTH |
A09855 Floor Votes:
Yes
Abbate
ER
Ceretto
Yes
Glick
Yes
Lentol
Yes
Murray
Yes
Ryan
Yes
Abinanti
Yes
Clark
Yes
Goldfeder
Yes
Lifton
Yes
Nolan
Yes
Saladino
Yes
Amedore
Yes
Colton
Yes
Goodell
Yes
Linares
Yes
Oaks
Yes
Sayward
Yes
Arroyo
ER
Conte
Yes
Gottfried
Yes
Lopez PD
ER
O'Donnell
ER
Scarborough
ER
Aubry
Yes
Cook
Yes
Graf
Yes
Lopez VJ
Yes
Ortiz
Yes
Schimel
Yes
Barclay
Yes
Corwin
Yes
Gunther
Yes
Losquadro
Yes
Palmesano
Yes
Schimminger
Yes
Barrett
Yes
Crespo
Yes
Hanna
Yes
Lupardo
ER
Paulin
Yes
Simanowitz
Yes
Barron
Yes
Crouch
Yes
Hawley
Yes
Magee
Yes
Peoples Stokes
Yes
Simotas
Yes
Benedetto
Yes
Curran
Yes
Heastie
Yes
Magnarelli
Yes
Perry
Yes
Skartados
Yes
Blankenbush
Yes
Cusick
Yes
Hevesi
Yes
Maisel
Yes
Pretlow
Yes
Smardz
Yes
Boyland
ER
Cymbrowitz
Yes
Hikind
Yes
Malliotakis
EL
Quart
ER
Stevenson
Yes
Boyle
Yes
DenDekker
Yes
Hooper
Yes
Markey
Yes
Ra
Yes
Sweeney
Yes
Braunstein
Yes
Dinowitz
Yes
Jacobs
Yes
Mayer
ER
Rabbitt
Yes
Tedisco
Yes
Brennan
Yes
Duprey
Yes
Jaffee
Yes
McDonough
Yes
Raia
Yes
Tenney
Yes
Brindisi
Yes
Englebright
ER
Jeffries
ER
McEneny
Yes
Ramos
Yes
Thiele
Yes
Bronson
Yes
Espinal
Yes
Johns
ER
McKevitt
Yes
Reilich
Yes
Titone
ER
Brook Krasny
Yes
Farrell
Yes
Jordan
Yes
McLaughlin
Yes
Reilly
Yes
Titus
ER
Burling
Yes
Finch
Yes
Katz
ER
Meng
Yes
Rivera J
ER
Tobacco
Yes
Butler
Yes
Fitzpatrick
Yes
Kavanagh
Yes
Miller D
Yes
Rivera N
Yes
Walter
Yes
Cahill
Yes
Friend
Yes
Kearns
ER
Miller JM
Yes
Rivera PM
Yes
Weinstein
Yes
Calhoun
Yes
Gabryszak
EL
Kellner
ER
Miller MG
Yes
Roberts
Yes
Weisenberg
Yes
Camara
Yes
Galef
Yes
Kolb
Yes
Millman
Yes
Robinson
Yes
Weprin
Yes
Canestrari
Yes
Gantt
ER
Lancman
Yes
Montesano
ER
Rodriguez
Yes
Wright
Yes
Castelli
Yes
Gibson
Yes
Latimer
Yes
Morelle
Yes
Rosenthal
Yes
Zebrowski
Yes
Castro
Yes
Giglio
Yes
Lavine
Yes
Moya
Yes
Russell
Yes
Mr. Speaker
‡ Indicates voting via videoconference
A09855 Text:
Go to top STATE OF NEW YORK ________________________________________________________________________ 9855--A IN ASSEMBLY April 18, 2012 ___________ Introduced by M. of A. ZEBROWSKI, CUSICK, ORTIZ -- read once and referred to the Committee on Health -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said commit- tee AN ACT to amend the public health law, in relation to adding synthetic cannabinoids to the schedule of controlled substances The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Schedule I of section 3306 of the public health law is 2 amended by adding a new subdivision (g) to read as follows: 3 (g) Synthetic cannabinoids. Unless specifically exempted or unless 4 listed in another schedule, any material, compound, mixture, or prepara- 5 tion which contains any quantity of the following substances, their 6 salts, isomers (whether optical, positional, or geometric), homologues 7 (analogs), and salts of isomers and homologues (analogs), unless specif- 8 ically exempted, within the specific chemical designation: 9 (1) Naphthoylindoles. Any compound containing a 3-(1-Naphthyl) indole 10 structure with substitution at the nitrogen atom of the indole ring by 11 an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 12 1-(N-methyl-2-piperidinyl) methyl, or 2-(4-morpholinyl) ethyl group, 13 whether or not further substituted in the indole ring to any extent and 14 whether or not substituted in the naphthyl ring to any extent. (Other 15 names in this structural class include but are not limited to: JWH-015, 16 JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, JWH-210, JWH-398, 17 AM-2201, and WIN 552l2). 18 (2) Naphthylmethylindoles. Any compound containing a 1 19 H-indol-3-yl-(1-naphthyl) methane structure with substitution at the 20 nitrogen atom of the indole ring by analkyl, haloalkyl, alkenyl, cyclo- 21 allcylmethyl, cycloalkylethyl, I-(N-methyl-2-piperidinyl) methyl, or 22 2-(4-morpholinyl) ethyl group, whether or not further substituted in the 23 indole ring to any extent and whether or not substituted in the naphthyl 24 ring to any extent. (Other names in this structural class include but 25 are not limited to: JWH-175 and JWH-184). EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD15220-03-2A. 9855--A 2 1 (3) Naphthoylpyrroles. Any compound containing a 3-(1-naphthoyl) 2 pyrrole structure with substitution at the nitrogen atom of the pyrrole 3 ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 4 1-(N-methyl-2-piperidinyl) methyl, or 2-(4-morpholinyl) ethyl group, 5 whether or not further substituted in the pyrrole ring to any extent and 6 whether or not substituted in the naphthyl ring to any extent. (Other 7 names in this structural class include but are not limited to: RVH-307). 8 (4) Naphthylmethylindenes. Any compound containing a naphthylidene 9 indene structure with substitution at the 3-position of the indene ring 10 by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 11 1-(N-methyl-2-piperidinyl) methyl, or 2-(4-morpholinyl) ethyl group, 12 whether or not further substituted in the indene ring to any extent and 13 whether or not substituted in the naphthyl ring to any extent. (Other 14 names in this structural class include but are not limited to: JWH-176). 15 (5) Phenylacetylindoles. Any compound containing a 3-phenylacetylin- 16 dole structure with substitution at the nitrogen atom of the indole ring 17 by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 18 1-(N-methyl-2-piperidinyl) methyl, or morpholinyl) ethyl group, whether 19 or not further substituted in the indole ring to any extent and whether 20 or not substituted in the phenyl ring to any extent. (Other names in 21 this structural class include but are not limited to: RCS-8 (SR-18), 22 JWH-250, JWH-203, JWH-251, and JWH-302). 23 (6) Cyclohexyiphenols. Any compound containing a 24 2-(3-hydroxycyclohexyl) phenol structure with substitution at the 5-po- 25 sition of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkyl- 26 methyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl, or 27 2-(4-morpholinyl) ethyl group, whether or not substituted in the cyclo- 28 hexyl ring to any extent. (Other names in this structural class include 29 but are not limited to: CP 47,497 (and homologues (analogs)), cannabicy- 30 clohexanol, and CP 55,940). 31 (7) Benzoylindoles. Any compound containing a 3-(benzoyl) indole 32 structure with substitution at the nitrogen atom of the indole ring by 33 an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 34 l-(N-methyl-2-piperidinyl) methyl, or 2-(4-morpholinyl) ethyl group, 35 whether or not further substituted in the indole ring to any extent and 36 whether or not substituted in the phenyl ring to any extent. (Other 37 names in this structural class include but are not limited to: AIvI 694, 38 Pravadoline (WIN 48,098), RCS 4, and AM-679). 39 (8) [2,3-Dihydro-5-methyl-3-(4-morpholinylniethyl)pyrrolo40[1,2,3-del-i, 4-benzoxazin-6-yl]-l-napthalenylmethanone. (Other names in 41 this structural class include but are not limited to: WIN 55,212-2). 42 (9) (6aR 1 OaR)-9-(hydroxymethyl)-6, 43 6-dimethyl-3-(2-methyloctan-2-yl)-6a,7, 10, 1 Oa 44 tetrahydrobenzo[cjchromen-1-ol 7370]. (Other names in this structural 45 class include but are not limited to: HU-210). 46 (10) Adamantoylindoles. Any compound containing a 3-(1-adamantoyl) 47 indole structure with substitution at the nitrogen atom of the indole 48 ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 49 1-(N-methyl-2-piperidinyl) methyl, or 2-(4-morpholinyl) ethyl group, 50 whether or not further substituted in the adamantyl ring system to any 51 extent. (Other names in this structural class include but are not limit- 52 ed to: AM-1248). 53 § 2. This act shall take effect on the ninetieth day after it shall 54 have become a law.